المؤلفون: Schoettler, ML, Carreras, E, Cho, B, Dandoy, CE, Ho, VT, Jodele, S, Moissev, I, Sanchez-Ortega, I, Srivastava, A, Atsuta, Y, Carpenter, P, Koreth, J, Kroger, N, Ljungman, P, Page, K, Popat, U, Shaw, BE, Sureda, A, Soiffer, R, Vasu, S

المصدر: Transplantation and cellular therapy. 29(3):151-163

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:152592862

المؤلفون: Schoettler ML; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Westbrook A; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, Georgia, USA., Watkins B; Children's Hospital, New Orleans, Tulane Pediatric Hematology/Oncology, New Orleans, Louisiana, USA., Stenger E; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Chonat S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA., Williams KM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia, USA.

المصدر: British journal of haematology [Br J Haematol] 2024 Jul; Vol. 205 (1), pp. 243-255. Date of Electronic Publication: 2024 May 30.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

مواضيع طبية MeSH: Hematopoietic Stem Cell Transplantation*/adverse effects , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/etiology , Thrombotic Microangiopathies*/etiology , Thrombotic Microangiopathies*/epidemiology , Thrombotic Microangiopathies*/prevention & control, Humans ; Female ; Male ; Child ; Adolescent ; Adult ; Child, Preschool ; Middle Aged ; Age Factors ; Young Adult ; Risk Factors ; Time Factors ; Infant ; Incidence

المؤلفون: Schoettler ML; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia. Electronic address: Michelle.Schoettler@emory.edu., Ofori J; Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Bryson E; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Spencer K; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Qayed M; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Stenger E; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Bidgoli A; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Chonat S; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia., Westbrook A; Pediatric Biostatistics Core, Department of Pediatrics, Emory University, Atlanta, Georgia., Williams KM; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jun 25. Date of Electronic Publication: 2024 Jun 25.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

المؤلفون: Schoettler ML; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia. Electronic address: Michelle.Schoettler@emory.edu., Williams KM; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Emory University, Atlanta, Georgia.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Jun 03. Date of Electronic Publication: 2024 Jun 03.

نوع المنشور: Letter

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

المؤلفون: Smith MA; Department of Pediatrics, Division of Critical Care Medicine, University of California, San Francisco, San Francisco, CA, United States., Cheng G; Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of California, San Francisco, San Francisco, CA, United States., Phelan R; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States., Brazauskas R; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States., Strom J; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States., Ahn KW; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States., Hamilton BK; Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, United States., Peterson A; Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI, United States., Savani B; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States., Schoemans H; Department of Haematology, University Hospital Gasthuisberg, Leuven, Belgium., Schoettler ML; Children's Healthcare of Atlanta, Emory University, Atlanta, GA, United States., Sorror M; Department of Hematology-Oncology, Fred Hutchinson Cancer Center, Seattle, WA, United States., Keller RL; Department of Pediatrics, Division of Neonatology, University of California, San Francisco, San Francisco, CA, United States., Higham CS; Department of Pediatrics, Division of Allergy, Immunology, and BMT, University of California, San Francisco, San Francisco, CA, United States., Dvorak CC; Department of Pediatrics, Division of Allergy, Immunology, and BMT, University of California, San Francisco, San Francisco, CA, United States., Fineman JR; Department of Pediatrics, Division of Critical Care Medicine, University of California, San Francisco, San Francisco, CA, United States., Zinter MS; Department of Pediatrics, Division of Critical Care Medicine, University of California, San Francisco, San Francisco, CA, United States.; Department of Pediatrics, Division of Allergy, Immunology, and BMT, University of California, San Francisco, San Francisco, CA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2024 May 29; Vol. 14, pp. 1415984. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Schoettler ML; Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA., Lehmann L; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Kao PC; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Chen N; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Jodele S; Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Medical Center, Cincinnati, OH., Chonat S; Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA., Williams KM; Division Blood and Marrow Transplantation, Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA., London WB; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Duncan C; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Dandoy C; Division of Bone Marrow Transplantation and Immune Deficiency, Department of Pediatrics, Cincinnati Children's Medical Center, Cincinnati, OH.

المصدر: Blood advances [Blood Adv] 2024 Mar 12; Vol. 8 (5), pp. 1220-1233.

نوع المنشور: Multicenter Study; Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Graft vs Host Disease*/drug therapy , Graft vs Host Disease*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects, Child ; Humans ; Antibodies, Monoclonal, Humanized/therapeutic use ; Patient Acceptance of Health Care ; Retrospective Studies

المؤلفون: Schoettler ML; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., French K; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Harris A; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Bryson E; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Deeb L; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Hudson Z; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Obordo J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Chandrakasan S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Parikh S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Watkins B; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Stenger E; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Chonat S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Westbrook A; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA., Switchenko J; Winship Cancer Center, Biostatistics, Atlanta, Georgia, USA., Williams KM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Pediatric Hematopoietic Cellular Therapy, Atlanta, Georgia, USA.

المصدر: American journal of hematology [Am J Hematol] 2024 Mar; Vol. 99 (3), pp. 370-379. Date of Electronic Publication: 2024 Jan 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Thrombotic Microangiopathies*/diagnosis , Thrombotic Microangiopathies*/etiology , Thrombotic Microangiopathies*/therapy , Hematopoietic Stem Cell Transplantation*/adverse effects , Fibrin Fibrinogen Degradation Products*, Humans ; Child ; Prognosis ; Prospective Studies ; Cohort Studies ; Retrospective Studies

المؤلفون: Schoettler ML; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia. Electronic address: Michelle.Schoettler@emory.edu., Patel S; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Bryson E; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Deeb L; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Watkins B; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Qayed M; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Chandrakasan S; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Fitch T; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Silvis K; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Jones J; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Chonat S; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia., Williams KM; Aflac Cancer and Blood Disorders Center, Emory University, Children's Healthcare of Atlanta, Atlanta, Georgia.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2024 Mar; Vol. 30 (3), pp. 336.e1-336.e8. Date of Electronic Publication: 2023 Dec 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Compassionate Use Trials*/adverse effects , Thrombotic Microangiopathies*/drug therapy , Thrombotic Microangiopathies*/etiology , Thrombotic Microangiopathies*/diagnosis , Antibodies, Monoclonal, Humanized*, Adult ; Child ; Infant ; Humans ; Mannose-Binding Protein-Associated Serine Proteases/therapeutic use ; Complement System Proteins/therapeutic use ; Complement Inactivating Agents/therapeutic use ; Lectins/therapeutic use ; Steroids/therapeutic use

المؤلفون: Patel PA; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia; Pediatric Infectious Disease at Children's Healthcare of Atlanta, Emory University Department of Pediatrics, Atlanta, Georgia. Electronic address: pratik.patel@emory.edu., Teherani MF; Division of Pediatric Infectious Diseases, University of Texas Southwestern Medical Center, Dallas, Texas., Xiang Y; Department of Pediatrics, Emory University, Atlanta, Georgia., Bernardo V; Children's Healthcare of Atlanta, Atlanta, Georgia., Chandrakasan S; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Goggin KP; Pediatric Infectious Disease at Children's Healthcare of Atlanta, Emory University Department of Pediatrics, Atlanta, Georgia., Haight A; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Horwitz E; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Liang WH; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Parikh SH; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Schoettler ML; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Spencer K; Children's Healthcare of Atlanta, Atlanta, Georgia., Stenger E; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Watkins B; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Williams KM; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Leung K; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia., Jaggi P; Pediatric Infectious Disease at Children's Healthcare of Atlanta, Emory University Department of Pediatrics, Atlanta, Georgia., Qayed M; Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, Georgia.

المصدر: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Dec; Vol. 29 (12), pp. 778.e1-778.e6. Date of Electronic Publication: 2023 Sep 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

مواضيع طبية MeSH: Anti-Bacterial Agents*/therapeutic use , Hematopoietic Stem Cell Transplantation*/adverse effects, Child ; Child, Preschool ; Humans ; Fever/drug therapy ; Fever/etiology ; Retrospective Studies

المؤلفون: Raghunandan S; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA. sraghu2@emory.edu., Gorfinkel L; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Bratrude B; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Suessmuth Y; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA., Hebert K; Dana-Farber Cancer Institute, Boston, MA, USA., Neuberg D; Dana-Farber Cancer Institute, Boston, MA, USA., Williams KM; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA., Schoettler ML; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA., Langston AA; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Kean LS; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Qayed M; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA., Horan J; Dana-Farber Cancer Institute, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Watkins BK; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, and Emory University, Atlanta, GA, USA.

المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2023 Nov; Vol. 58 (11), pp. 1260-1263. Date of Electronic Publication: 2023 Aug 14.

نوع المنشور: Letter

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

مواضيع طبية MeSH: Hematologic Neoplasms*/therapy , Graft vs Host Disease*/prevention & control , Hematopoietic Stem Cell Transplantation*, Humans ; Child ; Abatacept ; Bone Marrow Transplantation ; Unrelated Donors ; Histocompatibility Testing ; Retrospective Studies